Significant Reactions
Effective Jul 9, 2004MGL c. 111, §§ 3, 51 through 56, and 184BDepartment of Public Health
- (A) All fatal transfusion reactions shall be reported to the Bureau of Biologics of the FDA and to the Department.
- (B) All fatal donor reactions shall be reported to the Department.